Nestle Sues RenaGum Maker Over Kidney Disease Treatment

Law360, Washington (August 26, 2013, 8:27 PM ET) -- Nestle Health Science SA slammed Mastix Medica LLC with an infringement suit in New Jersey federal court on Friday, claiming the company's kidney disease treatment gum violates a Nestle patent for the method.

According to Nestle's complaint, Mastix's RenaGum product infringes on its patent-in-suit, U.S. Patent Number 7,915,898, entitled “oral compositions for absorption of phosphorous compounds.” The gum uses chitosan to treat hypophosphatemia, or a phosphate deficiency, to help manage patients' renal disease.

Although Nestle didn't mention whether it or its subsidiary CM&D Pharma Ltd. are...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required

Case Information

Case Title

NESTLE HEALTH SCIENCE S.A. et al v. MASTIX MEDICA, LLC

Case Number

2:13-cv-05072

Court

New Jersey

Nature of Suit

Patent

Judge

Stanley R. Chesler

Date Filed

August 23, 2013

Sections

Law Firms Mentioned

Companies Mentioned